Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study (Q42210312)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 July 2014

Language	Label	Description	Also known as
English	Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study	scientific article published on 29 July 2014

Statements

scholarly article

1 reference

Europe PubMed Central

18 October 2017

Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study (English)

1 reference

Europe PubMed Central

18 October 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hiromitsu Kumada

1

object named as

Hiromitsu Kumada

1 reference

Europe PubMed Central

18 October 2017

3

object named as

Namiki Izumi

1 reference

Europe PubMed Central

18 October 2017

author name string

Norio Hayashi

2

1 reference

Europe PubMed Central

18 October 2017

Takeshi Okanoue

4

1 reference

Europe PubMed Central

18 October 2017

Hirohito Tsubouchi

5

1 reference

Europe PubMed Central

18 October 2017

Hiroshi Yatsuhashi

6

1 reference

Europe PubMed Central

18 October 2017

Mai Kato

7

1 reference

Europe PubMed Central

18 October 2017

Ki Rito

8

1 reference

Europe PubMed Central

18 October 2017

Yuji Komada

9

1 reference

Europe PubMed Central

18 October 2017

Chiharu Seto

10

1 reference

Europe PubMed Central

18 October 2017

Shoichiro Goto

11

1 reference

Europe PubMed Central

18 October 2017

publication date

29 July 2014

1 reference

Europe PubMed Central

18 October 2017

Hepatology Research

1 reference

Europe PubMed Central

18 October 2017

45

1 reference

Europe PubMed Central

18 October 2017

5

1 reference

Europe PubMed Central

18 October 2017

501-513

1 reference

Europe PubMed Central

18 October 2017

Changing trends in hepatitis C infection over the past 50 years in Japan

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

The global burden of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Hepatocellular carcinoma in the Asia pacific region

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Telaprevir for retreatment of HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Response-guided telaprevir combination treatment for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs).

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1-infected patients in Japan: the DRAGON study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12375

21 January 2018

Identifiers

10.1111/HEPR.12375

1 reference

Europe PubMed Central

18 October 2017

1 reference

Europe PubMed Central

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42210312&oldid=1936002829"